Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2022-11-03 2022-10-13
Drug Identification Number 02230640 02230640
Brand name TOBRAMYCIN INJECTION TOBRAMYCIN INJECTION
Common or Proper name TOBRAMYCIN INJECTION TOBRAMYCIN INJECTION
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 40MG 40MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 30mL 30mL
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-01 2022-09-01
Estimated end date 2023-01-17 2023-01-17
Actual end date 2022-09-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments